Construction and Manipulation of a New Kaposi's Sarcoma-Associated Herpesvirus Bacterial Artificial Chromosome Clone
暂无分享,去创建一个
T. Oh | Jihyun F. Kim | Shou-Jiang Gao | Jae U. Jung | A. Ensser | D. Ganem | Kevin F. Brulois | A. S. Lee | Sun Hwa Lee | Hye-Ra Lee | Z. Tóth | Heesoon Chang | J. Myoung | L. Wong
[1] Jae U. Jung,et al. Negative Elongation Factor-Mediated Suppression of RNA Polymerase II Elongation of Kaposi's Sarcoma-Associated Herpesvirus Lytic Gene Expression , 2012, Journal of Virology.
[2] Shou-Jiang Gao,et al. Direct and efficient cellular transformation of primary rat mesenchymal precursor cells by KSHV. , 2012, The Journal of clinical investigation.
[3] W. Brune,et al. Construction of a Lytically Replicating Kaposi's Sarcoma-Associated Herpesvirus , 2011, Journal of Virology.
[4] D. Ganem,et al. Generation of a doxycycline-inducible KSHV producer cell line of endothelial origin: maintenance of tight latency with efficient reactivation upon induction. , 2011, Journal of virological methods.
[5] R. Means,et al. The MARCH Family E3 Ubiquitin Ligase K5 Alters Monocyte Metabolism and Proliferation through Receptor Tyrosine Kinase Modulation , 2011, PLoS pathogens.
[6] T. Schulz,et al. Kaposi's Sarcoma-Associated Herpesvirus Bacterial Artificial Chromosome Contains a Duplication of a Long Unique-Region Fragment within the Terminal Repeat Region , 2011, Journal of Virology.
[7] Qiyi Tang,et al. Herpesvirus BACs: Past, Present, and Future , 2010, Journal of biomedicine & biotechnology.
[8] Ethel Cesarman,et al. Kaposi's sarcoma and its associated herpesvirus , 2010, Nature Reviews Cancer.
[9] P. Lehner,et al. Identification of a Lysosomal Pathway Regulating Degradation of the Bone Morphogenetic Protein Receptor Type II* , 2010, The Journal of Biological Chemistry.
[10] J. Trowsdale,et al. Ubiquitination of lysine-331 by Kaposi's sarcoma-associated herpesvirus protein K5 targets HFE for lysosomal degradation , 2010, Proceedings of the National Academy of Sciences.
[11] P. Laird,et al. Epigenetic Analysis of KSHV Latent and Lytic Genomes , 2010, PLoS pathogens.
[12] R. Desrosiers,et al. Glycoprotein gene sequence variation in rhesus monkey rhadinovirus. , 2010, Virology.
[13] P. Lehner,et al. Kaposi’s Sarcoma-Associated Herpesvirus K3 and K5 Proteins Block Distinct Steps in Transendothelial Migration of Effector Memory CD4+ T Cells by Targeting Different Endothelial Proteins , 2010, The Journal of Immunology.
[14] D. Ganem. KSHV and the pathogenesis of Kaposi sarcoma: listening to human biology and medicine. , 2010, The Journal of clinical investigation.
[15] Blossom Damania,et al. Kaposi sarcoma-associated herpesvirus (KSHV): molecular biology and oncogenesis. , 2010, Cancer letters.
[16] R. Means,et al. Characterization of the rhesus fibromatosis herpesvirus MARCH family member rfK3. , 2010, Virology.
[17] T. Schulz,et al. The contribution of systems biology and reverse genetics to the understanding of Kaposi’s sarcoma-associated herpesvirus pathogenesis in endothelial cells , 2009, Thrombosis and Haemostasis.
[18] K. Mansfield,et al. Non-Human Primate Model of Kaposi's Sarcoma-Associated Herpesvirus Infection , 2009, PLoS pathogens.
[19] A. Moses,et al. Molecular Mechanism of BST2/Tetherin Downregulation by K5/MIR2 of Kaposi's Sarcoma-Associated Herpesvirus , 2009, Journal of Virology.
[20] P. Lehner,et al. The trafficking and regulation of membrane receptors by the RING-CH ubiquitin E3 ligases. , 2009, Experimental cell research.
[21] T. Seo,et al. Centrifugal enhancement of Kaposi's sarcoma-associated virus infection of human endothelial cells in vitro. , 2008, Journal of virological methods.
[22] Jae U. Jung,et al. Immune evasion in Kaposi's sarcoma-associated herpes virus associated oncogenesis. , 2008, Seminars in cancer biology.
[23] T. Schulz,et al. Changes in the immune responses against human herpesvirus-8 in the disease course of posttransplant Kaposi sarcoma. , 2008, Transplantation.
[24] P. Rose,et al. Remodeling of Endothelial Adherens Junctions by Kaposi's Sarcoma-Associated Herpesvirus , 2008, Journal of Virology.
[25] Mair E. M. Thomas,et al. Natural killer cell evasion by an E3 ubiquitin ligase from Kaposi's sarcoma-associated herpesvirus. , 2008, Biochemical Society transactions.
[26] A. Chaturvedi,et al. Underestimation of relative risks by standardized incidence ratios for AIDS-related cancers. , 2008, Annals of epidemiology.
[27] Mair E. M. Thomas,et al. Down-regulation of NKG2D and NKp80 ligands by Kaposi's sarcoma-associated herpesvirus K5 protects against NK cell cytotoxicity , 2008, Proceedings of the National Academy of Sciences.
[28] C. Brander,et al. Kaposi's sarcoma-associated herpesvirus-specific immune reconstitution and antiviral effect of combined HAART/chemotherapy in HIV clade C-infected individuals with Kaposi's sarcoma , 2007, AIDS.
[29] L. Coscoy. Immune evasion by Kaposi's sarcoma-associated herpesvirus , 2007, Nature Reviews Immunology.
[30] S. Rafii,et al. In vivo-restricted and reversible malignancy induced by human herpesvirus-8 KSHV: a cell and animal model of virally induced Kaposi's sarcoma. , 2007, Cancer cell.
[31] D. Kedes,et al. Intracellular Kaposi's Sarcoma-Associated Herpesvirus Load Determines Early Loss of Immune Synapse Components , 2007, Journal of Virology.
[32] C. Boshoff,et al. Kaposi sarcoma herpesvirus-encoded vFLIP and vIRF1 regulate antigen presentation in lymphatic endothelial cells. , 2007, Blood.
[33] Bonnie Yen,et al. Construction of an Infectious Rhesus Rhadinovirus Bacterial Artificial Chromosome for the Analysis of Kaposi's Sarcoma-Associated Herpesvirus-Related Disease Development , 2007, Journal of Virology.
[34] M. Du,et al. Kaposi sarcoma-associated herpesvirus/human herpesvirus 8 and lymphoproliferative disorders , 2006, Journal of Clinical Pathology.
[35] R. Means,et al. Downregulation of Gamma Interferon Receptor 1 by Kaposi's Sarcoma-Associated Herpesvirus K3 and K5 , 2006, Journal of Virology.
[36] C. Lebbé,et al. Differences in the frequency and function of HHV8-specific CD8 T cells between asymptomatic HHV8 infection and Kaposi sarcoma. , 2006, Blood.
[37] A. McCormack,et al. Quantitative Membrane Proteomics Reveals New Cellular Targets of Viral Immune Modulators , 2006, PLoS pathogens.
[38] R. Means,et al. Kaposi sarcoma herpesvirus K5 removes CD31/PECAM from endothelial cells. , 2006, Blood.
[39] D. Kedes,et al. KSHV targets multiple leukocyte lineages during long-term productive infection in NOD/SCID mice. , 2006, The Journal of clinical investigation.
[40] G. Feuer,et al. KSHV/HHV-8 infection of human hematopoietic progenitor (CD34+) cells: persistence of infection during hematopoiesis in vitro and in vivo. , 2006, Blood.
[41] P. Lehner,et al. Lysine‐63‐linked ubiquitination is required for endolysosomal degradation of class I molecules , 2006, The EMBO journal.
[42] J. von Einem,et al. Two-step red-mediated recombination for versatile high-efficiency markerless DNA manipulation in Escherichia coli. , 2006, BioTechniques.
[43] P. Moore,et al. Transcriptional Analysis of Latent and Inducible Kaposi's Sarcoma-Associated Herpesvirus Transcripts in the K4 to K7 Region , 2005, Journal of Virology.
[44] Shou-Jiang Gao,et al. Early and sustained expression of latent and host modulating genes in coordinated transcriptional program of KSHV productive primary infection of human primary endothelial cells. , 2005, Virology.
[45] D. Dittmer,et al. Role of Notch Signal Transduction in Kaposi's Sarcoma-Associated Herpesvirus Gene Expression , 2005, Journal of Virology.
[46] P. Lehner,et al. Downregulation of cell surface receptors by the K3 family of viral and cellular ubiquitin E3 ligases , 2005, Immunological reviews.
[47] D. Ganem,et al. RNAs in the Virion of Kaposi's Sarcoma-Associated Herpesvirus , 2005, Journal of Virology.
[48] K. Cadwell,et al. Ubiquitination on Nonlysine Residues by a Viral E3 Ubiquitin Ligase , 2005, Science.
[49] D. Ganem,et al. Regulation of CD1d expression and function by a herpesvirus infection. , 2005, The Journal of clinical investigation.
[50] J. Vieira,et al. Use of the red fluorescent protein as a marker of Kaposi's sarcoma-associated herpesvirus lytic gene expression. , 2004, Virology.
[51] B. Chandran,et al. Concurrent Expression of Latent and a Limited Number of Lytic Genes with Immune Modulation and Antiapoptotic Function by Kaposi's Sarcoma-Associated Herpesvirus Early during Infection of Primary Endothelial and Fibroblast Cells and Subsequent Decline of Lytic Gene Expression , 2004, Journal of Virology.
[52] D. Ganem,et al. Lytic KSHV infection inhibits host gene expression by accelerating global mRNA turnover. , 2004, Molecular cell.
[53] K. Früh,et al. Downregulation of Major Histocompatibility Complex Class I by Human Ubiquitin Ligases Related to Viral Immune Evasion Proteins , 2004, Journal of Virology.
[54] K. Yamanishi,et al. Activation of human herpesvirus 8 open reading frame K5 independent of ORF50 expression. , 2002, Virus research.
[55] K. Früh,et al. Immune evasion by a novel family of viral PHD/LAP-finger proteins of gamma-2 herpesviruses and poxviruses. , 2002, Virus research.
[56] U. Koszinowski,et al. K3-mediated evasion of CD8+ T cells aids amplification of a latent γ-herpesvirus , 2002, Nature Immunology.
[57] Shou-Jiang Gao,et al. Efficient Infection by a Recombinant Kaposi's Sarcoma-Associated Herpesvirus Cloned in a Bacterial Artificial Chromosome: Application for Genetic Analysis , 2002, Journal of Virology.
[58] D. Ganem,et al. Functional Organization of MIR2, a Novel Viral Regulator of Selective Endocytosis* , 2002, The Journal of Biological Chemistry.
[59] P. Stevenson,et al. MHC class I ubiquitination by a viral PHD/LAP finger protein. , 2001, Immunity.
[60] M. Falchi,et al. Transcription Pattern of Human Herpesvirus 8 Open Reading Frame K3 in Primary Effusion Lymphoma and Kaposi's Sarcoma , 2001, Journal of Virology.
[61] D. Ganem,et al. A viral protein that selectively downregulates ICAM-1 and B7-2 and modulates T cell costimulation. , 2001, The Journal of clinical investigation.
[62] Frederick Y. Wu,et al. Spindle Cell Conversion by Kaposi's Sarcoma-Associated Herpesvirus: Formation of Colonies and Plaques with Mixed Lytic and Latent Gene Expression in Infected Primary Dermal Microvascular Endothelial Cell Cultures , 2001, Journal of Virology.
[63] M. Corbellino,et al. Major histocompatibility complex class I molecules are down-regulated at the cell surface by the K5 protein encoded by Kaposi's sarcoma-associated herpesvirus/human herpesvirus-8. , 2001, The Journal of general virology.
[64] R. Johnson,et al. Inhibition of natural killer cell-mediated cytotoxicity by Kaposi's sarcoma-associated herpesvirus K5 protein. , 2000, Immunity.
[65] D. Ganem,et al. Kaposi's sarcoma-associated herpesvirus encodes two proteins that block cell surface display of MHC class I chains by enhancing their endocytosis. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[66] Jae U. Jung,et al. Downregulation of Major Histocompatibility Complex Class I Molecules by Kaposi's Sarcoma-Associated Herpesvirus K3 and K5 Proteins , 2000, Journal of Virology.
[67] Jiguo Chen,et al. Identification and Analysis of the K5 Gene of Kaposi's Sarcoma-Associated Herpesvirus , 2000, Journal of Virology.
[68] M. Reitz,et al. Comparison of Genetic Variability at Multiple Loci across the Genomes of the Major Subtypes of Kaposi’s Sarcoma-Associated Herpesvirus Reveals Evidence for Recombination and for Two Distinct Types of Open Reading Frame K15 Alleles at the Right-Hand End , 1999, Journal of Virology.
[69] D. Scadden. AIDS-related malignancies. , 1998, Current opinion in oncology.
[70] W. Hammerschmidt,et al. Cloning and mutagenesis of a herpesvirus genome as an infectious bacterial artificial chromosome. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[71] M. Reitz,et al. Strain variability among Kaposi sarcoma-associated herpesvirus (human herpesvirus 8) genomes: evidence that a large cohort of United States AIDS patients may have been infected by a single common isolate , 1997, Journal of virology.
[72] C. Boshoff,et al. Kaposi's sarcoma-associated herpesvirus infects endothelial and spindle cells , 1995, Nature Medicine.
[73] P. Karlovsky,et al. Hot spot for Tn1000 insertions in cloned repressor gene of the L phage. , 1986, Plasmid.
[74] Stanley N Cohen,et al. Translocation specificity of the Tn3 element: Characterization of sites of multiple insertions , 1980, Cell.
[75] Gregory A. Smith,et al. En passant mutagenesis: a two step markerless red recombination system. , 2010, Methods in molecular biology.
[76] C. Sánchez-Rivas,et al. Tn1000 (γδ) insertions stabilize pBR322-derived recombinant plasmids in Escherichia coli , 2004, Biotechnology Letters.
[77] U. Koszinowski,et al. K3-mediated evasion of CD8(+) T cells aids amplification of a latent gamma-herpesvirus. , 2002, Nature immunology.